Form D · Pharmaceuticals
METABOLIC SOLUTIONS DEVELOPMENT CO LLC
Kalamazoo, MI · CIK 0001422580
Offering snapshot reported Feb 6, 2019 · SEC filing
- Reported sold
- $200K Offering amount: $200K
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 30, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 6, 2019 | Initial | $200,000 | No comparison | 15 | SEC filing |
| Sep 24, 2015 | Amendment | $16,135,409 | $4,354,303vs Jul 18, 2014 | 30 | SEC filing |
| Jul 18, 2014 | Amendment | $11,781,106 | $9,281,106vs Aug 14, 2012 | 23 | SEC filing |
| Feb 5, 2014 | Initial | $98,191 | No comparison | 2 | SEC filing |
| Aug 14, 2012 | Initial | $2,500,000 | No comparison | 1 | SEC filing |
| Aug 11, 2011 | Initial | $6,810,000 | No comparison | 23 | SEC filing |
| Oct 7, 2010 | Initial | $14,981,243 | No comparison | 24 | SEC filing |
| Mar 24, 2009 | Initial | Yet to sell | No comparison | Not reported | SEC filing |
| Dec 21, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 21, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 21, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-332236
Source: Form D, filed Feb 6, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Benoit | Director |
| Gerald Callahan | Director, Executive |
| Gerard Colca | Director, Executive |
| Sandi Doctor | Director |
| Michael Jandernoa | Director |
| Rolf Kletzien | Director, Executive |
| John Landis | Director |
| Mark Olesnavage | Director, Executive |
| William Parfet | Director |
| Jim Schultz | Director |
| Angeline Shashlo | Executive |
| James Vanderlugt | Executive |
| James Vander Lugt | Executive |
| Robert Zerbe | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
161 East Michigan Avenue 4 Th Floor
Kalamazoo, MI, 49007
Kalamazoo, MI, 49007